The BPC-157/TB-500 blend combines two peptides with overlapping yet distinct pathways in tissue repair. While each peptide is extensively studied on its own, research suggests their combination produces synergistic effects that exceed what either achieves alone.

BPC-157 (Body Protection Compound-157) is a stable gastric pentadecapeptide derived from a protective protein in the stomach lining. It promotes healing through angiogenesis (new blood vessel formation), growth factor regulation, and reduced inflammation. Critically, research shows BPC-157 increases actin production at the gene level and upregulates growth hormone receptor expression on tendon fibroblasts — extending their lifespan and regenerative capacity.

TB-500 (Thymosin Beta-4) is a 43-amino-acid actin-binding protein that plays a key role in cell migration and tissue regeneration. It sequesters actin monomers, directing them to where they’re most useful for building the filaments cells need to move. With BPC-157 increasing actin production and GH receptor expression, TB-500 ensures fibroblasts have the cytoskeletal resources to take full advantage of their enhanced signaling and extended survival.

Together, these peptides create a comprehensive repair environment: more actin (BPC-157), better actin utilization (TB-500), enhanced growth hormone sensitivity (BPC-157), and improved cell migration (both). For research teams investigating tissue regeneration, wound healing, or musculoskeletal repair, this combination provides a synergistic platform that addresses multiple aspects of the healing cascade simultaneously.

For research use only. Not for human consumption.